| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 |
| filingDate |
2016-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4e7218c30fcfb894b82c28e19729e72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f0efd1f916e95e4227361a6972c77f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_591f89a61acae81f1f4e46cc50e26ccf |
| publicationDate |
2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3275434-A1 |
| titleOfInvention |
An extended release oral dosage form |
| abstract |
An extended release oral dosage form for highly soluble and highly permeable pharmaceutically active PARP inhibitors. The invention relates to the extended release oral dosage form comprising 2-((R)-2-Methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide (veliparib) and a gel-forming polymer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110035751-A |
| priorityDate |
2016-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |